Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 5 Apr 23 424B5 Prospectus supplement for primary offering
- 18 Apr 22 424B5 Prospectus supplement for primary offering
- 15 Apr 22 424B5 Prospectus supplement for primary offering
- 13 Apr 22 424B5 Prospectus supplement for primary offering
- 14 Jun 21 424B5 Prospectus supplement for primary offering
- 9 Jun 21 EFFECT Notice of effectiveness
-
28 May 21 S-3 Shelf registration
OCX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference, in the Prospectus constituting a part of this Registration Statement on Form S-3, of our report dated March 19, 2021 relating to the financial statements of OncoCyte Corporation appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ OUM & CO. LLP
San Francisco, California
May 28, 2021